Glenmark Pharmaceuticals is currently trading at Rs. 513.80, up by 9.75 points or 1.93% from its previous closing of Rs. 504.05 on the BSE.
The scrip opened at Rs. 515.00 and has touched a high and low of Rs. 529.00 and Rs. 512.00 respectively. So far 69,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 550.80 and a 52 week low of Rs. 286.15.
The current market cap of the company is Rs. 13,910.00 crore.
The promoters holding in the company stood at 48.32% while Institutions and Non-Institutions held 40.01% and 11.67% respectively.
The company has posted over 8-fold rise its net profit at Rs 109.03 crore for third quarter ended December 31, 2012 as compared to Rs 13.14 crore for the same quarter in the previous year. Total income of the company has increased by 35.18% at Rs 555.94 crore for quarter under review as compared to Rs 411.25 crore for the quarter ended December 31, 2011.
On consolidated basis, the company has posted over 5-fold rise its net profit at Rs 212.91 crore for the quarter ended December 31, 2012 as compared to Rs 44.82 crore for the same quarter in the previous year. Total income of the company has increased by 33.08% at Rs 1386.76 crore for quarter under review as compared to Rs 1042.06 crore for the quarter ended December 31, 2011.
